Neoadjuvant Therapy for Rectal Cancer
- PMID: 29994956
- PMCID: PMC6044457
- DOI: 10.1097/DCR.0000000000001139
Neoadjuvant Therapy for Rectal Cancer
Abstract
A 63-year-old man presents to his primary care doctor with a one-month history of blood in his stools. He is referred for a colonoscopy and found to have a friable mass along the anterior wall just proximal to the second rectal fold. A biopsy confirms moderately-differentiated adenocarcinoma. The patient then obtains pelvic magnetic resonance imaging and chest, abdomen, and pelvis computed tomography demonstrating local invasion of the primary tumor into the mesorectal fat (T3), no suspicious regional lymph nodes (N0), and no evidence of distant metastatic disease (M0).
Conflict of interest statement
Figures


References
-
- Cedermark B, Dahlberg M, Glimelius B, Påhlman L, Rutqvist LE, Wilking N. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980–987. - PubMed
-
- Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Dutch Colorectal Cancer Group Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–646. - PubMed
-
- Monson JRT, Weiser MR, Buie WD, et al. Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (revised) Dis Colon Rectum. 2013;56:535–550. - PubMed
-
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology - Rectal Cancer (Ver 3.2017) 2017 Available from: https://www.nccn.org/professionals/physician_gls/pdf/rectal_blocks.pdf. Accessed December 21, 2017.
-
- Nougaret S, Rouanet P, Molinari N, et al. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology. 2012;263:409–418. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources